Latest AI and machine learning research in oncology/hematology for healthcare professionals.
BACKGROUND: Accurate prediction of postoperative recurrence in lung adenocarcinoma (LUAD) is essential for guiding clinical decision-making and improving patient outcomes. Although various predictive models have been developed, most rely on complex genomic analyses and high-dimensional clinical data. The complexity of these approaches substantially limits their feasibility for routine clinical use...
Chemodynamic therapy (CDT), which harnesses endogenous chemical energy within the tumor microenvironment (TME), has shown high potential for precise cancer treatment. However, its efficacy is often limited by the mildly acidic and reductive nature of the TME that compromises catalyst stability and activity. Developing catalysts capable of maintaining robust performance under such physiological con...
BACKGROUND: Cervical cancer is the fourth most common malignant tumor in women globally, with tobacco smoke being a major environmental risk factor. T...
BACKGROUND: Dihydroorotate dehydrogenase (DHODH), an important enzyme in de-novo pyrimidine synthesis, and its dysregulation has been frequently assoc...
BACKGROUND: Older survivors of cancer face heightened risk of depression and anxiety related to cancer experiences, fear of recurrence, and aging-rela...
PURPOSE: This study addresses critical gaps in automated lymphoma segmentation from PET/CT imaging, often overlooked in prior work. While deep learnin...
BACKGROUND: Some researchers have explored the application of radiomics-based machine learning to detect preoperative muscle invasion, high-grade tumo...
Cell-free DNA can be used for early cancer detection, minimal residual disease monitoring, and post-treatment risk stratification. However, current as...
Metabolic biomarkers offer promising opportunities for lung cancer risk assessment and early detection. This study aimed to identify metabolites with ...
BRAF mutations are key oncogenic alterations across multiple malignancies, including melanoma, thyroid carcinoma, colorectal cancer, non-small cell lu...
Clinical oncology increasingly depends on molecular information, but many assays still detach analytes from the histological coordinates in which diag...
Osimertinib is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor that improves clinical outcomes in patients with E...
Ultrasound has emerged as a versatile, non-invasive imaging technique in dermatology, offering real-time, high-resolution visualization of cutaneous s...
Breast fibrosis (BF) after radiotherapy remains one of the most dreaded late toxicities in breast cancer care, yet multiple additive predictors strugg...
Malignant intestinal obstruction (MIO) is a severe complication of advanced cancer. Traditional static assessment models struggle to capture its dynam...
Colorectal cancer(CRC) recurrence remains a challenge despite curative surgery and adjuvant therapy. Integrating clinicopathological and liquid biopsy...
Large language models (LLMs) like GPT have been proposed to support complex clinical decision-making. This study evaluated the performance of GPT-base...
Acute myeloid leukemia (AML) is a genetically and phenotypically heterogeneous hematological malignancy. Here, to better define this clinically taxing...
Skip metastasis-defined as lateral lymph node metastasis(N1b) in the absence of central lymph node involvement-represents a distinct yet underrecogniz...
Cancer drug resistance, driven by complex genetic mutations, epigenetic plasticity, and tumor microenvironment interactions, remains the primary cause...